Intellipharmaceutics / Par to Make Immediate Commercial Launch of 15 and…

Intellipharmaceutics / Par to Make Immediate Commercial Launch of 15 and…

…marketed by Novartis Pharmaceuticals Corporation. According to Source Healthcare Analytics, sales for the 12 months ended October 2013 of Focalin XR® 15 and 30 mg, respectively, in the U.S. were approximately…

10
Like
Save

Comments

Write a comment

*